176 related articles for article (PubMed ID: 37815873)
1. Hepatitis B virus infection disrupts homologous recombination in hepatocellular carcinoma by stabilizing resection inhibitor ADRM1.
Zeng M; Tang Z; Ren L; Wang H; Wang X; Zhu W; Mao X; Li Z; Mo X; Chen J; Han J; Kong D; Ji J; Carr AM; Liu C
J Clin Invest; 2023 Dec; 133(23):. PubMed ID: 37815873
[TBL] [Abstract][Full Text] [Related]
2. Chromatin remodelling factor BAF155 protects hepatitis B virus X protein (HBx) from ubiquitin-independent proteasomal degradation.
Chen H; Zhang Y; Ye S; Wu Q; Lin Y; Sheng K; Chen W; Lin X; Lin X
Emerg Microbes Infect; 2019; 8(1):1393-1405. PubMed ID: 31533543
[TBL] [Abstract][Full Text] [Related]
3. Tumor Suppressor p53 Inhibits Hepatitis B Virus Replication by Downregulating HBx via E6AP-Mediated Proteasomal Degradation in Human Hepatocellular Carcinoma Cell Lines.
Lim HY; Han J; Yoon H; Jang KL
Viruses; 2022 Oct; 14(10):. PubMed ID: 36298868
[TBL] [Abstract][Full Text] [Related]
4. The Antiresection Activity of the X Protein Encoded by Hepatitis Virus B.
Ren L; Zeng M; Tang Z; Li M; Wang X; Xu Y; Weng Y; Wang X; Wang H; Guo L; Zuo B; Wang X; Wang S; Lou J; Tang Y; Mu D; Zheng N; Wu X; Han J; Carr AM; Jeggo P; Liu C
Hepatology; 2019 Jun; 69(6):2546-2561. PubMed ID: 30791110
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B Virus X Protein Is Stabilized by the Deubiquitinating Enzyme VCPIP1 in a Ubiquitin-Independent Manner by Recruiting the 26S Proteasome Subunit PSMC3.
Wu Q; Zhang L; Xu X; Zhang Y; Shi J; Lin X; Chen W
J Virol; 2022 Jul; 96(13):e0061122. PubMed ID: 35695579
[TBL] [Abstract][Full Text] [Related]
6. The X-linked tumor suppressor TSPX interacts and promotes degradation of the hepatitis B viral protein HBx via the proteasome pathway.
Kido T; Ou JH; Lau YF
PLoS One; 2011; 6(7):e22979. PubMed ID: 21829568
[TBL] [Abstract][Full Text] [Related]
7. HBx Protein Contributes to Liver Carcinogenesis by H3K4me3 Modification Through Stabilizing WD Repeat Domain 5 Protein.
Gao W; Jia Z; Tian Y; Yang P; Sun H; Wang C; Ding Y; Zhang M; Zhang Y; Yang D; Tian Z; Zhou J; Ruan Z; Wu Y; Ni B
Hepatology; 2020 May; 71(5):1678-1695. PubMed ID: 31544250
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B Virus Core Promoter A1762T/G1764A (TA)/T1753A/T1768A Mutations Contribute to Hepatocarcinogenesis by Deregulating Skp2 and P53.
Yan J; Yao Z; Hu K; Zhong Y; Li M; Xiong Z; Deng M
Dig Dis Sci; 2015 May; 60(5):1315-24. PubMed ID: 25567052
[TBL] [Abstract][Full Text] [Related]
9. Proteasomal activator 28 gamma stabilizes hepatitis B virus X protein by competitively inhibiting the Siah-1-mediated proteasomal degradation.
Han J; Kim H; Jeong H; Yoon H; Jang KL
Biochem Biophys Res Commun; 2021 Nov; 578():97-103. PubMed ID: 34555669
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma.
Ali A; Abdel-Hafiz H; Suhail M; Al-Mars A; Zakaria MK; Fatima K; Ahmad S; Azhar E; Chaudhary A; Qadri I
World J Gastroenterol; 2014 Aug; 20(30):10238-48. PubMed ID: 25132741
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus X protein-induced SH2 domain-containing 5 (SH2D5) expression promotes hepatoma cell growth via an SH2D5-transketolase interaction.
Zheng Y; Ming P; Zhu C; Si Y; Xu S; Chen A; Wang J; Zhang B
J Biol Chem; 2019 Mar; 294(13):4815-4827. PubMed ID: 30659097
[TBL] [Abstract][Full Text] [Related]
12. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus X protein activates proteasomal activator 28 gamma expression via upregulation of p53 levels to stimulate virus replication.
Yeom S; Jeong H; Kim SS; Jang KL
J Gen Virol; 2018 May; 99(5):655-666. PubMed ID: 29611800
[TBL] [Abstract][Full Text] [Related]
14. E3 ubiquitin ligase Siah-1 facilitates poly-ubiquitylation and proteasomal degradation of the hepatitis B viral X protein.
Zhao J; Wang C; Wang J; Yang X; Diao N; Li Q; Wang W; Xian L; Fang Z; Yu L
FEBS Lett; 2011 Oct; 585(19):2943-50. PubMed ID: 21878328
[TBL] [Abstract][Full Text] [Related]
15. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J
Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069
[TBL] [Abstract][Full Text] [Related]
16. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus-associated hepatocellular carcinoma with Smc5/6 complex deficiency is susceptible to PARP inhibitors.
Funato K; Otsuka M; Sekiba K; Miyakawa Y; Seimiya T; Shibata C; Kishikawa T; Fujishiro M
Biochem Biophys Res Commun; 2022 Jun; 607():89-95. PubMed ID: 35367833
[TBL] [Abstract][Full Text] [Related]
18. Sorafenib overcomes the chemoresistance in HBx-expressing hepatocellular carcinoma cells through down-regulation of HBx protein stability and suppresses HBV gene expression.
Kim HY; Jung HU; Yoo SH; Yoo KS; Cheong J; Park BS; Yun I; Yoo YH
Cancer Lett; 2014 Dec; 355(1):61-9. PubMed ID: 25218348
[TBL] [Abstract][Full Text] [Related]
19. Interaction of the hepatitis B virus X protein with the lysine methyltransferase SET and MYND domain-containing 3 induces activator protein 1 activation.
Hayashi M; Deng L; Chen M; Gan X; Shinozaki K; Shoji I; Hotta H
Microbiol Immunol; 2016 Jan; 60(1):17-25. PubMed ID: 26616333
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus X protein stimulates high mobility group box 1 secretion and enhances hepatocellular carcinoma metastasis.
Chen S; Dong Z; Yang P; Wang X; Jin G; Yu H; Chen L; Li L; Tang L; Bai S; Yan H; Shen F; Cong W; Wen W; Wang H
Cancer Lett; 2017 May; 394():22-32. PubMed ID: 28216372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
